Buprenorphine Sublingual Spray

DRUG2 trials

Sponsors

INSYS Therapeutics Inc

Conditions

Pain, PostoperativePost-operative Pain

Phase 2

Study of Buprenorphine Sublingual Spray Versus Standard of Care Narcotic Therapy for the Treatment of Post-Operative Pain

CompletedNCT03254459

INSYS Therapeutics IncPain, Postoperative

Start: 2017-09-12End: 2017-11-13Updated: 2018-10-29

Phase 3

Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain

TerminatedNCT02310581

INSYS Therapeutics IncPost-operative Pain

Start: 2015-02-24End: 2015-03-19Updated: 2017-08-09